DNA and Cell Biology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 9, 2024
Breast
cancer
(BC)
is
a
significant
contributor
to
cancer-related
deaths
in
women,
and
it
has
complex
connections
with
obesity
aging.
This
review
explores
the
interaction
between
aging
relation
development
progression
of
BC,
focusing
on
controlling
role
microRNAs
(miRNAs).
Obesity,
characterized
by
excess
adipose
tissue,
contributes
proinflammatory
environment
metabolic
dysregulation,
which
are
important
tumor
development.
Aging,
associated
cellular
senescence
systemic
changes,
further
exacerbates
these
conditions.
miRNAs,
small
noncoding
RNAs
that
regulate
gene
expression,
play
key
roles
processes,
impacting
pathways
involved
cell
proliferation,
apoptosis,
metastasis,
either
as
suppressors
or
oncogenes.
Importantly,
specific
miRNAs
implicated
mediating
impact
BC.
Exploring
regulatory
networks
controlled
provides
valuable
information
new
targets
for
therapy
predictive
markers,
demonstrating
potential
using
miRNA-based
interventions
treat
BC
obese
elderly
individuals.
emphasizes
importance
integrated
research
strategies
understand
obesity,
aging,
miRNA
regulation
Molecular Cancer,
Journal Year:
2022,
Volume and Issue:
21(1)
Published: Nov. 2, 2022
Tumors
are
comprised
of
both
cancer
cells
and
surrounding
stromal
components.
As
an
essential
part
the
tumor
microenvironment,
stroma
is
highly
dynamic,
heterogeneous
commonly
tumor-type
specific,
it
mainly
includes
noncellular
compositions
such
as
extracellular
matrix
unique
cancer-associated
vascular
system
well
a
wide
variety
cellular
components
including
activated
fibroblasts,
mesenchymal
cells,
pericytes.
All
these
elements
operate
with
each
other
in
coordinated
fashion
collectively
promote
initiation,
progression,
metastasis
therapeutic
resistance.
Over
past
few
decades,
numerous
studies
have
been
conducted
to
study
interaction
crosstalk
between
neoplastic
cells.
Meanwhile,
we
also
witnessed
exponential
increase
investigation
recognition
critical
roles
solid
tumors.
A
series
clinical
trials
targeting
launched
continually.
In
this
review,
introduce
discuss
current
advances
understanding
various
their
cancers.
We
elaborate
on
potential
novel
approaches
for
tumor-stroma-based
targeting,
aim
leap
from
bench
bedside.
Cell Death and Disease,
Journal Year:
2023,
Volume and Issue:
14(9)
Published: Sept. 4, 2023
Abstract
The
tumor
microenvironment
(TME)
is
made
up
of
cells
and
extracellular
matrix
(non-cellular
component),
cellular
components
include
cancer
non-malignant
such
as
immune
stromal
cells.
These
three
types
establish
complex
signals
in
the
body
further
influence
genesis,
development,
metastasis
participate
resistance
to
anti-tumor
therapy.
It
has
attracted
scholars
study
TME
due
significant
efficacy
checkpoint
inhibitors
(ICI)
chimeric
antigen
receptor
T
(CAR-T)
solid
tumors
hematologic
tumors.
After
more
than
10
years
efforts,
role
strategy
treating
based
on
have
developed
rapidly.
Moreover,
ICI
been
recommended
by
guidelines
first-
or
second-line
treatment
strategies
a
variety
At
same
time,
another
major
class
TME,
which
also
play
very
important
metabolism,
growth,
metastasis,
evasion
resistance.
Stromal
can
be
recruited
from
neighboring
non-cancerous
host
formed
transdifferentiation
they
development
drug
secreting
various
factors
exosomes,
participating
angiogenesis
regulating
response
matrix.
However,
with
deepening
understanding
cells,
people
found
that
not
only
effect
promoting
but
inhibit
some
cases.
In
this
review,
we
will
introduce
origin
well
specific
mechanism
tumorigenesis
for
We
focus
tumor-associated
fibroblasts
(CAFs),
mesenchymal
stem
(MSCs),
adipocytes
(CAAs),
endothelial
(TECs)
pericytes
(PCs)
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 12, 2024
The
breast
cancer
tumor
microenvironment
(TME)
is
dynamic,
with
various
immune
and
non-immune
cells
interacting
to
regulate
progression
anti-tumor
immunity.
It
now
evident
that
the
within
TME
significantly
contribute
resistance
conventional
newly
developed
therapies.
Both
in
play
critical
roles
onset,
uncontrolled
proliferation,
metastasis,
evasion,
Consequently,
molecular
cellular
components
of
have
emerged
as
promising
therapeutic
targets
for
developing
novel
treatments.
primarily
comprises
cells,
stromal
vasculature,
infiltrating
cells.
Currently,
numerous
clinical
trials
targeting
specific
are
underway.
However,
complexity
its
impact
on
evasion
immunity
necessitate
further
research
develop
improved
multifaceted
nature
arises
from
their
phenotypic
functional
plasticity,
which
endows
them
both
pro
during
progression.
In
this
review,
we
discuss
current
understanding
recent
advances
anti-tumoral
functions
implications
safe
effective
therapies
control
progress.
Antioxidants,
Journal Year:
2025,
Volume and Issue:
14(2), P. 201 - 201
Published: Feb. 10, 2025
Oxidative
stress
is
a
common
event
involved
in
cancer
pathophysiology,
frequently
accompanied
by
unique
lipid
metabolic
reprogramming
phenomena.
caused
mainly
an
imbalance
between
the
production
of
reactive
oxygen
species
(ROS)
and
antioxidant
system
cells.
Emerging
evidence
has
reported
that
oxidative
regulates
expression
activity
metabolism-related
enzymes,
leading
to
alteration
cellular
metabolism;
this
involves
significant
increase
fatty
acid
synthesis
shift
way
which
lipids
are
taken
up
utilized.
The
dysregulation
metabolism
provides
abundant
intermediates
synthesize
biological
macromolecules
for
rapid
proliferation
cells;
moreover,
it
contributes
maintenance
intracellular
redox
homeostasis
producing
variety
reducing
agents.
Moreover,
derivatives
metabolites
play
critical
roles
signal
transduction
within
cells
tumor
microenvironment
evades
immune
destruction
facilitates
invasion
metastasis.
These
findings
suggest
close
relationship
during
malignant
progression
cancers.
This
review
focuses
on
crosstalk
reprogramming,
in-depth
insight
into
modulation
ROS
cancers
discusses
potential
strategies
targeting
therapy.
As
cardiovascular
disease
(CVD)
morbidity
and
mortality
increase
yearly,
this
study
aimed
to
explore
the
potential
of
weight-adjusted-waist
index
(WWI)
its
relation
long-term
in
patients
with
CVD.
The
diagnosis
CVD
was
based
on
standardized
medical
condition
questionnaires
that
incorporated
participants'
self-reported
physician
diagnoses.
WWI
(cm/√kg)
is
a
continuous
variable
calculated
as
waist
circumference
(WC,
cm)
divided
by
square
root
body
weight
(kg).
For
analysis
purposes,
participants
were
into
four
groups
quartiles
(Q1
-
Q4)
WWI.
study's
primary
outcome
all-cause
CVD,
secondary
outcome,
sample
weights
complex
survey
designs
used
ensure
reliable,
accurate
results.
final
included
4,445
participants.
In
fully
adjusted
model,
highest
quartile
(WWI
>
12.05
cm/√
kg)
showed
higher
rate
compared
lowest
<
11.03
(HR
=
1.37,
95%
CI:
1.03,
1.82,
P
0.05).
risk
increased
linear
association
congestive
heart
failure,
attack
(P-overall
0.05,
nonlinear
0.05);
nonlinearly
associated
coronary
angina
Survival
curve
further
all
cause
high
group
(Q4)
(P
0.001).
time-dependent
receiver
operating
characteristic
(ROC)
WWI's
area
under
curves
(AUC)
for
5-
10-year
survival
rates
0.76
0.792
0.734
0.757
mortality.
AUC
than
those
mass
(BMI)
WC
(all
0.01).
Our
findings
indicate
positively
an
Additionally,
values
strengthen
meaningful
prognostic
marker,
underscoring
utility
clinical
practice
assessing
Cancers,
Journal Year:
2023,
Volume and Issue:
15(3), P. 726 - 726
Published: Jan. 24, 2023
Adipocytes
are
the
main
components
in
breast
tissue,
and
cancer-associated
adipocytes
(CAAs)
one
of
most
important
tumor
microenvironment
cancer
(BC).
Bidirectional
regulation
was
found
between
CAAs
BC
cells.
facilitates
dedifferentiation
adjacent
to
form
with
morphological
biological
changes.
increase
secretion
multiple
cytokines
adipokines
promote
tumorigenesis,
progression,
metastasis
by
remodeling
extracellular
matrix,
changing
aromatase
expression,
metabolic
reprogramming,
shaping
immune
microenvironment.
also
associated
therapeutic
response
provide
potential
targets
therapy.
The
present
review
provides
a
comprehensive
description
crosstalk
discusses
strategies
target
overcome
treatment
resistance.
Drug Resistance Updates,
Journal Year:
2023,
Volume and Issue:
71, P. 101002 - 101002
Published: Aug. 22, 2023
Adenocarcinoma
is
a
common
type
of
malignant
tumor,
originating
from
glandular
epithelial
cells
in
various
organs,
such
as
pancreas,
breast,
lung,
stomach,
colon,
rectus,
and
prostate.
For
patients
who
lose
the
opportunity
for
radical
surgery,
medication
available
to
provide
potential
clinical
benefits.
However,
drug
resistance
big
obstacle
obtain
desired
prognosis.
In
this
review,
we
summary
treatment
strategies
mechanisms
adenocarcinoma
different
including
pancreatic
cancer,
gastric
adenocarcinoma,
colorectal
lung
prostate
cancer.
Although
underlying
molecular
involved
vary
one
organ
other,
there
are
several
targets
that
universal
targeting
these
molecules
could
potentially
reverse
adenocarcinomas.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(5), P. 1572 - 1572
Published: March 3, 2023
With
the
recent
leaps
in
medicine,
landscape
of
our
knowledge
regarding
adipose
tissue
has
changed
dramatically:
it
is
now
widely
regarded
as
a
fully
functional
endocrine
organ.
In
addition,
evidence
from
observational
studies
linked
pathogenesis
diseases
like
breast
cancer
with
and
mainly
adipokines
that
are
secreted
its
microenvironment,
catalog
continuously
expanding.
Examples
include
leptin,
visfatin,
resistin,
osteopontin,
more.
This
review
aims
to
encapsulate
current
clinical
concerning
major
their
link
oncogenesis.
Overall,
there
have
been
numerous
meta-analyses
contribute
evidence,
however
more
targeted
larger-scale
still
expected
solidify
utility
BC
prognosis
reliability
follow-up
markers.